BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 9610566)

  • 1. Neuroendocrine cells of the prostate and neuroendocrine differentiation in prostatic carcinoma: a review of morphologic aspects.
    di Sant'Agnese PA
    Urology; 1998 May; 51(5A Suppl):121-4. PubMed ID: 9610566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine differentiation in prostatic malignancy.
    di Sant'Agnese PA; Cockett AT
    Cancer; 1996 Jul; 78(2):357-61. PubMed ID: 8674017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prostatic endocrine-paracrine (neuroendocrine) regulatory system and neuroendocrine differentiation in prostatic carcinoma: a review and future directions in basic research.
    Di Sant'Agnese PA; Cockett AT
    J Urol; 1994 Nov; 152(5 Pt 2):1927-31. PubMed ID: 7933249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications.
    di Sant'Agnese PA
    Cancer; 1992 Jul; 70(1 Suppl):254-68. PubMed ID: 1350941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine differentiation in human prostatic carcinoma.
    di Sant'Agnese PA
    Hum Pathol; 1992 Mar; 23(3):287-96. PubMed ID: 1313390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study.
    Turbat-Herrera EA; Herrera GA; Gore I; Lott RL; Grizzle WE; Bonnin JM
    Arch Pathol Lab Med; 1988 Nov; 112(11):1100-5. PubMed ID: 2460064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
    Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
    Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prostatic adenocarcinoma with neuroendocrine differentiation of the small cell type].
    Rimoldi DA; Antonio Costa J; Roveto S; Rivero O
    Medicina (B Aires); 2001; 61(3):322-4. PubMed ID: 11474882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent neuroendocrine differentiation in prostatic carcinoma.
    di Sant' Agnese PA
    Semin Diagn Pathol; 2000 May; 17(2):149-61. PubMed ID: 10839615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prostatic neuroendocrine cells].
    Herrero M; Rodríguez A; Cejas H
    Rev Fac Cien Med Univ Nac Cordoba; 2002; 59(1):91-6. PubMed ID: 12934249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma.
    Aprikian AG; Cordon-Cardo C; Fair WR; Reuter VE
    Cancer; 1993 Jun; 71(12):3952-65. PubMed ID: 7685237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving concepts in prostatic neuroendocrine manifestations: from focal divergent differentiation to amphicrine carcinoma.
    Bellur S; Van der Kwast T; Mete O
    Hum Pathol; 2019 Mar; 85():313-327. PubMed ID: 30481509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine-paracrine cell types in the prostate and prostatic adenocarcinoma are postmitotic cells.
    Bonkhoff H; Stein U; Remberger K
    Hum Pathol; 1995 Feb; 26(2):167-70. PubMed ID: 7532147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine differentiation and prostatic carcinoma. The concept 'comes of age'.
    di Sant'Agnese PA
    Arch Pathol Lab Med; 1988 Nov; 112(11):1097-9. PubMed ID: 3178423
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuroendocrine differentiation in metastatic prostatic adenocarcinoma.
    Aprikian AG; Cordon-Cardo C; Fair WR; Zhang ZF; Bazinet M; Hamdy SM; Reuter VE
    J Urol; 1994 Apr; 151(4):914-9. PubMed ID: 8126824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine differentiation in prostatic carcinoma: an update.
    di Sant'Agnese PA
    Prostate Suppl; 1998; 8():74-9. PubMed ID: 9690666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposed morphologic classification of prostate cancer with neuroendocrine differentiation.
    Epstein JI; Amin MB; Beltran H; Lotan TL; Mosquera JM; Reuter VE; Robinson BD; Troncoso P; Rubin MA
    Am J Surg Pathol; 2014 Jun; 38(6):756-67. PubMed ID: 24705311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine differentiation in prostatic carcinoma.
    di Sant'Agnese PA; de Mesy Jensen KL
    Hum Pathol; 1987 Aug; 18(8):849-56. PubMed ID: 3610135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostatic adenocarcinoma with marked neuroendocrine differentiation.
    Islam AM; Kato H; Hayama M; Kobayashi S; Ota H; Nishizawa O
    Int J Urol; 2001 Jul; 8(7):412-5. PubMed ID: 11442667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paneth cell-like change and small cell carcinoma of the prostate. Two divergent forms of prostatic neuroendocrine differentiation.
    Weaver MG; Abdul-Karim FW; Srigley JR
    Am J Surg Pathol; 1992 Oct; 16(10):1013-6. PubMed ID: 1329569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.